Device Trial Radar · NCT04130737
The PQ Bypass Pivotal IDE Intra-arterial Stent Graft Study
Last checked: Nov 20, 2026Latest source record: Jul 10, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
188
Actual
Start
Aug 13, 2018
Primary completion
Jan 6, 2023
Study completion Feb 14, 2025
Sponsor
- Lead sponsor
- EndologixNot on our public-company list
- Sponsor type
- Industry
- Collaborators
- Syntactx; PQ Bypass, Inc.
- First posted
- Oct 17, 2019
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 18 years, up to 90 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The primary objective of the TORUS 2 IDE Clinical Study is to evaluate the safety and effectiveness of the TORUS Stent Graft System in the treatment of obstructive atherosclerotic lesions of the native SFA or the superficial femoral and/or proximal popliteal arteries.
Conditions
- Peripheral Arterial Disease
Interventions
TORUS Stent Graft SystemDevice
The TORUS Stent Graft is an intravascular prosthesis intended to improve blood flow in the area in which it is implanted and the TORUS Stent Graft Delivery System is a standard pin-and-pull delivery system used to implant the SG in the desired area. Use of the TORUS Stent Graft allows for improving blood flow in the peripheral vasculature.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Freedom From a Major Adverse Event (MAE)Time frame: 30 days
- Primary PatencyTime frame: 12 months
Locations
32 sites in 1 country. Site status is shown where the registry gives one.
Southwest CVA
Mesa, Arizona
Vascular Heart & Lung Associates
Mesa, Arizona
Phoenix Cardiovascular Research Group
Phoenix, Arizona
29 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.